These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37794663)

  • 1. Identification of Plasma Biomarkers in Drug-Naïve Schizophrenia Using Targeted Metabolomics.
    Su Q; Bi F; Yang S; Yan H; Sun X; Wang J; Qiu Y; Li M; Li S; Li J
    Psychiatry Investig; 2023 Sep; 20(9):818-825. PubMed ID: 37794663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of lipids and amino acids in plasma distinguish schizophrenia patients from controls: A targeted metabolomics study.
    Liu Y; Song X; Liu X; Pu J; Gui S; Xu S; Tian L; Zhong X; Zhao L; Wang H; Liu L; Xu G; Xie P
    Psychiatry Clin Neurosci; 2021 Apr; 75(4):138-144. PubMed ID: 33421228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia.
    Wang D; Cheng SL; Fei Q; Gu H; Raftery D; Cao B; Sun X; Yan J; Zhang C; Wang J
    Psychiatry Res; 2019 Feb; 272():18-29. PubMed ID: 30579177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential plasma biomarker panels identification for the diagnosis of first-episode schizophrenia and monitoring antipsychotic monotherapy with the use of metabolomics analyses.
    Song M; Liu Y; Zhou J; Shi H; Su X; Shao M; Yang Y; Wang X; Zhao J; Guo D; Liu Q; Zhang L; Zhang Y; Lv L; Li W
    Psychiatry Res; 2023 Mar; 321():115070. PubMed ID: 36706560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between alterations in plasma metabolites and treatment responses in antipsychotic-naïve female patients with schizophrenia.
    Wang X; Xie J; Ma H; Li G; Li M; Li S; Sun X; Zhao Y; Sun W; Yang S; Li J
    World J Biol Psychiatry; 2024 Feb; 25(2):106-115. PubMed ID: 37867221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia.
    Cao Y; Xu Y; Xia Q; Shan F; Liang J
    Neuropsychiatr Dis Treat; 2023; 19():1455-1462. PubMed ID: 37384352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics and lipidomics analyses by
    Tasic L; Pontes JGM; Carvalho MS; Cruz G; Dal Mas C; Sethi S; Pedrini M; Rizzo LB; Zeni-Graiff M; Asevedo E; Lacerda ALT; Bressan RA; Poppi RJ; Brietzke E; Hayashi MAF
    Schizophr Res; 2017 Jul; 185():182-189. PubMed ID: 28040324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma metabolomics of schizophrenia with cognitive impairment: A pilot study.
    Jiang Y; Sun X; Hu M; Zhang L; Zhao N; Shen Y; Yu S; Huang J; Li H; Yu W
    Front Psychiatry; 2022; 13():950602. PubMed ID: 36245866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of eicosanoids and related mediators in patients with schizophrenia.
    Wang D; Sun X; Yan J; Ren B; Cao B; Lu Q; Liu Y; Zeng J; Huang N; Xie Q; Gu H; Wang J
    J Psychiatr Res; 2018 Jul; 102():168-178. PubMed ID: 29674269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gut microbiome profile in patients with schizophrenia and healthy controls - A plausible non-invasive biomarker?
    Gokulakrishnan K; Nikhil J; Viswanath B; Thirumoorthy C; Narasimhan S; Devarajan B; Joseph E; David AKD; Sharma S; Vasudevan K; Sreeraj VS; Holla B; Shivakumar V; Debnath M; Venkatasubramanian G; Varambally S
    J Psychiatr Res; 2023 Jun; 162():140-149. PubMed ID: 37156128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study.
    Du Y; Chen L; Li XS; Li XL; Xu XD; Tai SB; Yang GL; Tang Q; Liu H; Liu SH; Zhang SY; Cheng Y
    Schizophr Bull; 2021 Apr; 47(3):615-623. PubMed ID: 33159208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients.
    Yan J; Chen Y; Ju P; Gao J; Zhang L; Li J; Wang K; Zhang J; Li C; Xia Q; Zhu C; Zhang X
    Front Psychiatry; 2022; 13():834539. PubMed ID: 35273531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of an assistive diagnostic model for schizophrenia with oxidative stress biomarkers.
    Wang S; Yuan X; Pang L; Song P; Jia R; Song X
    Front Pharmacol; 2023; 14():1158254. PubMed ID: 37007024
    [No Abstract]   [Full Text] [Related]  

  • 14. [Establishment of diagnostic model for schizophrenia based on neurotrophic factor and other biomarkers].
    Pang LJ; Li X; Yuan XX; Hei GR; Zhang LY; Wang SY; Chen YS; Song PL; Song XQ
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(17):1310-1315. PubMed ID: 37150680
    [No Abstract]   [Full Text] [Related]  

  • 15. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
    Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome and metabolism alterations in schizophrenia with metabolic syndrome severity.
    Zhao H; Zhu G; Zhu T; Ding B; Xu A; Gao S; Chao Y; Li N; Chen Y; Wang Z; Jie Y; Dong X
    BMC Psychiatry; 2024 Jul; 24(1):529. PubMed ID: 39048972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.
    Dong MX; Hu L; Wei YD; Chen GH
    Neurosci Lett; 2021 Feb; 745():135626. PubMed ID: 33440238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia.
    Okamoto N; Ikenouchi A; Watanabe K; Igata R; Fujii R; Yoshimura R
    Front Psychiatry; 2021; 12():763547. PubMed ID: 34975570
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder.
    Tasic L; Larcerda ALT; Pontes JGM; da Costa TBBC; Nani JV; Martins LG; Santos LA; Nunes MFQ; Adelino MPM; Pedrini M; Cordeiro Q; Bachion de Santana F; Poppi RJ; Brietzke E; Hayashi MAF
    J Psychiatr Res; 2019 Dec; 119():67-75. PubMed ID: 31568986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role between inflammatory cytokines and Tie-2 receptor levels and clinical symptoms in patients with first-episode schizophrenia.
    Yan F; Meng X; Cheng X; Pei W; Chen Y; Chen L; Zheng M; Shi L; Zhu C; Zhang X
    BMC Psychiatry; 2023 Jul; 23(1):538. PubMed ID: 37491201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.